CLINICAL_TRIALS trial_result · 2025-07-08

Clinical Trial Update: A Study to Evaluate EDP 938 Regimens in Children With RSV [Phase 2]

A Phase 2 study evaluating regimens of the RSV antiviral EDP-938 in children has completed and results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Sponsor: Enanta Pharmaceuticals, Inc | Conditions: Respiratory Syncytial Virus (RSV) | Phase 2 | Status: COMPLETED | Results posted: 2025-07-08